Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-25
1993-04-13
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142342, 5142345, 5142285, 514255, 514259, 514260, 544284, 544285, 544287, 544116, 544117, 544 57, 544 586, A61K 3154, A61K 31505, C07D23990, C07D23996
Patent
active
052023222
ABSTRACT:
Substituted quinazolinones and pyridopyrimidines of structural formula 1 ##STR1## are angiotensin II antagonists useful in the treatment of disorders related to the reninangiotensin system (RAS) such as hypertension, congestive heart failure, ocular hypertension and certain CNS disorders.
Allen Eric E.
Olson Richard E.
DiPrima Joseph F.
E. I. Du Pont de Nemours and Company
Grumbling Matthew V.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Quinazolinone and pyridopyrimidine a-II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolinone and pyridopyrimidine a-II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone and pyridopyrimidine a-II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155534